
Sign up to save your podcasts
Or


Moderna CEO Stephane Bancel speaks with Bloomberg's Alix Steele and Guy Johnson on the company's covid vaccine trials, found to be 94% effective. Sam Fazeli, Senior Pharmaceutical Analyst and Head of EMEA Research for Bloomberg Intelligence, and Sarah Ponczek, Bloomberg cross-asset reporter, weigh in on the news. Tuna Amobi, Equity Research Analyst at CFRA Research, on outlook for the travel and hospitality industry. Hosted by Paul Sweeney and Vonnie Quinn.
See omnystudio.com/listener for privacy information.
By Bloomberg3.8
381381 ratings
Moderna CEO Stephane Bancel speaks with Bloomberg's Alix Steele and Guy Johnson on the company's covid vaccine trials, found to be 94% effective. Sam Fazeli, Senior Pharmaceutical Analyst and Head of EMEA Research for Bloomberg Intelligence, and Sarah Ponczek, Bloomberg cross-asset reporter, weigh in on the news. Tuna Amobi, Equity Research Analyst at CFRA Research, on outlook for the travel and hospitality industry. Hosted by Paul Sweeney and Vonnie Quinn.
See omnystudio.com/listener for privacy information.

970 Listeners

1,170 Listeners

2,201 Listeners

420 Listeners

969 Listeners

198 Listeners

1,038 Listeners

185 Listeners

72 Listeners

1,302 Listeners

62 Listeners

78 Listeners

30 Listeners

59 Listeners

5 Listeners

58 Listeners

233 Listeners

234 Listeners

63 Listeners

85 Listeners

80 Listeners

76 Listeners

86 Listeners

403 Listeners

18 Listeners

12 Listeners

7 Listeners

2 Listeners

114 Listeners

22 Listeners